Blood levels and alkylating metabolites of cyclophosphamide in the mouse after Iv or oral administration

R. F. Struck, David S Alberts

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Blood levels of cyclophosphamide (CPA) and its alkylating metabolites in mice were determined after iv or oral administration of a 200-mg/kg dose of radiolabeled CPA. Individual metabolites (4-hydroxy-CPA, 4-keto-CPA, alcophosphamide, dechloroethyl-CPA, carboxyphosphamide, and phosphoramide mustard) were isolated from blood by solvent extraction and by thin-layer chromatography. Area-under-the-blood-decay-curve (AUC) values were determined for CPA and its alkylating metabolites to provide a basis for comparison of systemic exposure by iv or oral treatment. The total AUC values for alkylating metabolites of CPA was observed to be greater after iv administration, and AUC values for each of the individual metabolites were greater after iv treatment, except for the minor metabolite alcophosphamide. The methods in this study have been applied to one patient to data and will be used in future studies with other patients to determine relative AUC values for the oncolytic CPA metabolites 4-hydroxy-CPA and phosphoramide mustard.

Original languageEnglish (US)
Pages (from-to)765-770
Number of pages6
JournalCancer Treatment Reports
Volume68
Issue number5
StatePublished - 1984
Externally publishedYes

Fingerprint

Cyclophosphamide
Oral Administration
Area Under Curve
Thin Layer Chromatography
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Blood levels and alkylating metabolites of cyclophosphamide in the mouse after Iv or oral administration. / Struck, R. F.; Alberts, David S.

In: Cancer Treatment Reports, Vol. 68, No. 5, 1984, p. 765-770.

Research output: Contribution to journalArticle

@article{8df517c50ab4413fa3327b3eb2c1eafd,
title = "Blood levels and alkylating metabolites of cyclophosphamide in the mouse after Iv or oral administration",
abstract = "Blood levels of cyclophosphamide (CPA) and its alkylating metabolites in mice were determined after iv or oral administration of a 200-mg/kg dose of radiolabeled CPA. Individual metabolites (4-hydroxy-CPA, 4-keto-CPA, alcophosphamide, dechloroethyl-CPA, carboxyphosphamide, and phosphoramide mustard) were isolated from blood by solvent extraction and by thin-layer chromatography. Area-under-the-blood-decay-curve (AUC) values were determined for CPA and its alkylating metabolites to provide a basis for comparison of systemic exposure by iv or oral treatment. The total AUC values for alkylating metabolites of CPA was observed to be greater after iv administration, and AUC values for each of the individual metabolites were greater after iv treatment, except for the minor metabolite alcophosphamide. The methods in this study have been applied to one patient to data and will be used in future studies with other patients to determine relative AUC values for the oncolytic CPA metabolites 4-hydroxy-CPA and phosphoramide mustard.",
author = "Struck, {R. F.} and Alberts, {David S}",
year = "1984",
language = "English (US)",
volume = "68",
pages = "765--770",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Blood levels and alkylating metabolites of cyclophosphamide in the mouse after Iv or oral administration

AU - Struck, R. F.

AU - Alberts, David S

PY - 1984

Y1 - 1984

N2 - Blood levels of cyclophosphamide (CPA) and its alkylating metabolites in mice were determined after iv or oral administration of a 200-mg/kg dose of radiolabeled CPA. Individual metabolites (4-hydroxy-CPA, 4-keto-CPA, alcophosphamide, dechloroethyl-CPA, carboxyphosphamide, and phosphoramide mustard) were isolated from blood by solvent extraction and by thin-layer chromatography. Area-under-the-blood-decay-curve (AUC) values were determined for CPA and its alkylating metabolites to provide a basis for comparison of systemic exposure by iv or oral treatment. The total AUC values for alkylating metabolites of CPA was observed to be greater after iv administration, and AUC values for each of the individual metabolites were greater after iv treatment, except for the minor metabolite alcophosphamide. The methods in this study have been applied to one patient to data and will be used in future studies with other patients to determine relative AUC values for the oncolytic CPA metabolites 4-hydroxy-CPA and phosphoramide mustard.

AB - Blood levels of cyclophosphamide (CPA) and its alkylating metabolites in mice were determined after iv or oral administration of a 200-mg/kg dose of radiolabeled CPA. Individual metabolites (4-hydroxy-CPA, 4-keto-CPA, alcophosphamide, dechloroethyl-CPA, carboxyphosphamide, and phosphoramide mustard) were isolated from blood by solvent extraction and by thin-layer chromatography. Area-under-the-blood-decay-curve (AUC) values were determined for CPA and its alkylating metabolites to provide a basis for comparison of systemic exposure by iv or oral treatment. The total AUC values for alkylating metabolites of CPA was observed to be greater after iv administration, and AUC values for each of the individual metabolites were greater after iv treatment, except for the minor metabolite alcophosphamide. The methods in this study have been applied to one patient to data and will be used in future studies with other patients to determine relative AUC values for the oncolytic CPA metabolites 4-hydroxy-CPA and phosphoramide mustard.

UR - http://www.scopus.com/inward/record.url?scp=0021282243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021282243&partnerID=8YFLogxK

M3 - Article

VL - 68

SP - 765

EP - 770

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 5

ER -